CLINORIL Drug Patent Profile
✉ Email this page to a colleague
When do Clinoril patents expire, and when can generic versions of Clinoril launch?
Clinoril is a drug marketed by Merck and is included in one NDA.
The generic ingredient in CLINORIL is sulindac. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the sulindac profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clinoril
A generic version of CLINORIL was approved as sulindac by WATSON LABS on April 3rd, 1990.
Summary for CLINORIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Clinical Trials: | 9 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CLINORIL at DailyMed |
Recent Clinical Trials for CLINORIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Cancer Prevention Pharmaceuticals, Inc. | Phase 3 |
Stony Brook University | Phase 2 |
Children's Oncology Group | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for CLINORIL
US Patents and Regulatory Information for CLINORIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | CLINORIL | sulindac | TABLET;ORAL | 017911-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Merck | CLINORIL | sulindac | TABLET;ORAL | 017911-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CLINORIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck | CLINORIL | sulindac | TABLET;ORAL | 017911-002 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Merck | CLINORIL | sulindac | TABLET;ORAL | 017911-002 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Merck | CLINORIL | sulindac | TABLET;ORAL | 017911-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Merck | CLINORIL | sulindac | TABLET;ORAL | 017911-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CLINORIL
See the table below for patents covering CLINORIL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Austria | 327879 | ⤷ Try a Trial | |
Switzerland | 569708 | ⤷ Try a Trial | |
Yugoslavia | 35235 | ⤷ Try a Trial | |
Yugoslavia | 279575 | ⤷ Try a Trial | |
Switzerland | 569710 | ⤷ Try a Trial | |
Malaysia | 7400082 | SUBSTITUTED INDENYLACETIC ACIDS AND THEIR DERIVATIVES | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |